Shots: The approval is based on P-III CAPSTONE-1 study assessing Xofluza vs PBO or oseltamivir 75 mg (bid for 5days) in the US & Japan (N=1436) and P-II study in […]readmore
Tags : 20 yrs
Shots: Approval is based ongoing Ph 1/2 CheckMate-032, study is assessing 245 patients in two arms Opdivo vs platinum based therapy CheckMater-032 Results: ORR:12% (13/109); PR: 11% (12/109); CR: 0.9% […]readmore